Arkolith/Insider Trading/CDAK/Form 4

Cooney Charles L

DirectorCodiak BioSciences, Inc. (CDAK) · full profile →Form 4 · filed Jun 21, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2022Grant(A)2K—$02K
Jun 17, 2022Grant(A)8K—$08K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-023400) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML